Related Experiment Video
Updated: Jan 20, 2026

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
Published on: October 10, 2012
Biomarkers in Post-kala-azar Dermal Leishmaniasis
1Rotterdam Centre for Tropical Medicine, Rotterdam, Netherlands.
Post-kala-azar dermal leishmaniasis (PKDL) is a skin condition following visceral leishmaniasis. New biomarkers are crucial for accurate diagnosis and effective treatment monitoring of PKDL.
Area of Science:
- Dermatology
- Infectious Diseases
- Parasitology
Background:
- Post-kala-azar dermal leishmaniasis (PKDL) is a common sequela of visceral leishmaniasis (VL), affecting 10-60% of patients.
- PKDL presents as an asymptomatic skin rash, often on the face, with macules, papules, or nodules.
- Clinical diagnosis is challenging in endemic areas, necessitating reliable diagnostic tools.
Purpose of the Study:
- To review current biomarkers for Post-kala-azar dermal leishmaniasis (PKDL).
- To discuss promising new developments in PKDL biomarker research.
- To address the need for improved diagnostic and monitoring tools for PKDL.
Main Methods:
- Review of existing literature on PKDL biomarkers.
- Analysis of parasitological, serological, immunological, and pathological markers.
- Evaluation of clinical assessment methods, including grading and photography.
Main Results:
- Current diagnostic methods for PKDL have limitations in field settings.
- Parasitological confirmation is preferred for guiding drug treatment decisions.
- Assessing treatment response in PKDL is difficult due to slow healing, risking prolonged therapy.
Conclusions:
- There is a critical need for validated biomarkers in Post-kala-azar dermal leishmaniasis (PKDL).
- Biomarkers are essential for accurate diagnosis, differentiating PKDL from other skin conditions, and monitoring treatment efficacy.
- Future research should focus on developing and validating novel biomarkers for improved PKDL management.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Post-traumatic Stress Disorder
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Handwashing III: During the Procedure and Post-Procedure Steps
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Plant Cells and Tissues

